1-(Bromomethyl)-2,4-dimethylbenzene → HCID 59361478, Verbindung

HRID 888812

Reaktionsgleichung

Reaktionsgleichung von HRID 888812
[CH:1]12[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH:2]1[N:11]1[C:14](=[O:15])[C:13]([CH3:17])([CH3:16])[NH:12]1)[CH2:8]2.[CH3:18][C:19]1[CH:26]=[C:25]([CH3:27])[CH:24]=[CH:23][C:20]=1[CH2:21]Br>>[CH3:18][C:19]1[CH:26]=[C:25]([CH3:27])[CH:24]=[CH:23][C:20]=1[CH2:21][N:12]1[C:13]([CH3:17])([CH3:16])[C:14](=[O:15])[N:11]1[CH:2]1[CH:3]2[CH2:4][CH:5]3[CH2:6][CH:7]([CH2:8][CH:1]1[CH2:10]3)[CH2:9]2

Komponenten

3

Versuchsvorschrift

2-(Adamantan-2-yl)-4,4-dimethyl-1,2-diazetidin-3-one and 2,4-dimethylbenzyl bromide were used for a similar reaction and treatment as Process 6 of Example 1, and the title compound was obtained as a white crystalline powder.

Quellen und Nachweise

ORD-Eintrag
ord-cd9508c73282412da04eaf0bdab051bb
Quelldatensatz
uspto-grants-2012_08
Patentnummer
US08252781B2

Verknüpfte Notizen

Wird geladen…